Bernard Taverne, Alice Desclaux, Papa Salif Sow

CHAPITRE I-4Vieillissement accéléré et VIHHogan, D. B., C. MacKnight and H. Bergman (2003). "Models,definitions, and criteria of frailty." Aging Clin Exp Res 15(3 Suppl): 1-29.Jacobson, D. L., D. Spiegelman, T. K. Knox and I. B. Wilson(2008). "Evolution and predictors of change in total bone mineraldensity over time in HIV-infected men and women in the nutritionfor healthy living study." J Acquir Immune Defic Syndr 49(3):298-308.Justice, A. C. (2010). "HIV and aging: time for a new paradigm."Curr HIV/AIDS Rep 7(2): 69-76.Kohli, R., R. S. Klein, E. E. Schoenbaum, K. Anastos, H. Minkoffand H. S. Sacks (2006). "Aging and HIV infection." J Urban Health83(1): 31-42.Tebas, P., K. Yarasheski, K. Henry, S. Claxton, E. Kane, B. Bordenave,M. Klebert and W. G. Powderly (2004). "Evaluation of thevirological and metabolic effects of switching protease inhibitorcombination antiretroviral therapy to nevirapine-based therapy forthe treatment of HIV infection." AIDS Res Hum Retroviruses 20(6):589-94.Triant, V. A., T. T. Brown, H. Lee and S. K. Grinspoon (2008)."Fracture prevalence among human immunodeficiency virus(HIV)-infected versus non-HIV-infected patients in a large U.S.healthcare system." J Clin Endocrinol Metab 93(9): 3499-504.Yin, M., J. Dobkin, K. Brudney, C. Becker, J. L. Zadel, M. Manandhar,V. Addesso and E. Shane (2005). "Bone mass and mineralmetabolism in HIV+ postmenopausal women." Osteoporos Int16(11): 1345-52.Krieg, M. A., R. Barkmann, S. Gonnelli, A. Stewart, D. C. Bauer, L.Del Rio Barquero, J. J. Kaufman, R. Lorenc, P. D. Miller, W. P.Olszynski, C. Poiana, A. M. Schott, E. M. Lewiecki and D. Hans(2008). "Quantitative ultrasound in the management of osteoporosis:the 2007 ISCD Official Positions." J Clin Densitom 11(1):163-87.ird-00718213, version 1 - 16 Jul 2012Lohman, T. G., A. F. Roche and R. Martorell (1988). AnthropometricStandardization ReferenceManual, Human Kinetics Books Editors, USA.McComsey, G. A., P. Tebas, E. Shane, M. T. Yin, E. T. Overton, J.S. Huang, G. M. Aldrovandi, S. W. Cardoso, J. L. Santana and T. T.Brown (2010). "Bone disease in HIV infection: a practical reviewand recommendations for HIV care providers." Clin Infect Dis51(8): 937-46.Mercier, S., N. F. Gueye, A. Cournil, A. Fontbonne, N. Copin, I.Ndiaye, A. M. Dupuy, C. Cames, P. S. Sow, I. Ndoye, E. Delaporteand K. B. Simondon (2009). "Lipodystrophy and metabolicdisorders in HIV-1-infected adults on 4- to 9-year antiretroviraltherapy in Senegal: a case-control study." J Acquir Immune DeficSyndr 51(2): 224-30.Moayyeri, A., S. Kaptoge, N. Dalzell, S. Bingham, R. N. Luben, N.J. Wareham, J. Reeve and K. T. Khaw (2009). "Is QUS or DXAbetter for predicting the 10-year absolute risk of fracture?" J BoneMiner Res 24(7): 1319-25.Njeh, C. F., D. Hans, J. Li, B. Fan, T. Fuerst, Y. Q. He, E. Tsuda-Futami,Y. Lu, C. Y. Wu and H. K. Genant (2000). "Comparison of sixcalcaneal quantitative ultrasound devices: precision and hipfracture discrimination." Osteoporos Int 11(12): 1051-62.Onen, N. F., A. Agbebi, E. Shacham, K. E. Stamm, A. R. Onen andE. T. Overton (2009). "Frailty among HIV-infected persons in anurban outpatient care setting." J Infect 59(5): 346-52.Paccou, J., N. Viget, I. Legrout-Gerot, Y. Yazdanpanah and B. Cortet(2009). "Bone loss in patients with HIV infection." Joint Bone Spine.Phillips, A. N., J. Neaton and J. D. Lundgren (2008). "The role ofHIV in serious diseases other than AIDS." AIDS 22(18): 2409-18.Rockwood, K. (2005). "Frailty and its definition: a worthychallenge." J Am Geriatr Soc 53(6): 1069-70.Sharma, A., P. L. Flom, J. Weedon and R. S. Klein (2010)."Prospective study of bone mineral density changes in aging menwith or at risk for HIV infection." AIDS 24(15): 2337-45.Stellbrink, H. J., C. Orkin, J. R. Arribas, J. Compston, J. Gerstoft,E. Van Wijngaerden, A. Lazzarin, G. Rizzardini, H. G. Sprenger, J.Lambert, G. Sture, D. Leather, S. Hughes, P. Zucchi and H. Pearce(2010). "Comparison of changes in bone density and turnover withabacavir-lamivudine versus tenofovir-emtricitabine in HIV-infectedadults: 48-week results from the ASSERT study." Clin Infect Dis51(8): 963-72.50